pubmed.ncbi.nlm.nih.gov

Tramadol: basic pharmacology and emerging concepts - PubMed

Review

Tramadol: basic pharmacology and emerging concepts

Roy R Reeves et al. Drugs Today (Barc). 2008 Nov.

Abstract

Tramadol hydrochloride is a widely prescribed, centrally acting analgesic marketed in over 90 countries. Before being released in the U.S. in 1995, the drug had been available in Europe for almost two decades. Thus, the pharmacokinetic and pharmacodynamic properties of tramadol have been extensively investigated. However, additional information about the drug continues to be discovered. Tramadol exists as a racemic mixture with the (+)-enantiomer and the (-)-enantiomer, and at least some of their metabolites, having different effects. Tramadol has dual mechanisms of action by which analgesia may be achieved: micro-opioid receptor activation and enhancement of serotonin and norepinephrine transmission. Serotonin syndrome may occur in patients taking combinations of tramadol and other agents that increase serotonin activity. The relative degree of contribution of each mechanism toward pain control is not fully understood. By increasing serotonin and norepinephrine neurotransmission, tramadol may conceivably also exert a degree of antidepressant effect. Therefore, tramadol may be of particular value in patients with chronic pain who also suffer from depression. This drug has been shown to be beneficial in the treatment of a wide range of acute and chronic pain syndromes, including neuropathic pain. While abuse of tramadol may occur, several large studies have demonstrated that the incidence of abuse is rather low, about one case per 100,000 patients.

Copyright 2008 Prous Science, S.A.U. or its licensors. All rights reserved.

PubMed Disclaimer

Similar articles

  • [Pharmacology of tramadol].

    Dayer P, Desmeules J, Collart L. Dayer P, et al. Drugs. 1997;53 Suppl 2:18-24. doi: 10.2165/00003495-199700532-00006. Drugs. 1997. PMID: 9190321 Review. French.

  • In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.

    Shao L, Hewitt M, Jerussi TP, Wu F, Malcolm S, Grover P, Fang K, Koch P, Senanayake C, Bhongle N, Ribe S, Bakale R, Currie M. Shao L, et al. Bioorg Med Chem Lett. 2008 Mar 1;18(5):1674-80. doi: 10.1016/j.bmcl.2008.01.051. Epub 2008 Jan 18. Bioorg Med Chem Lett. 2008. PMID: 18242987

  • Tramadol: does it have a role in cancer pain management?

    Prommer EE. Prommer EE. J Opioid Manag. 2005 Jul-Aug;1(3):131-8. doi: 10.5055/jom.2005.0032. J Opioid Manag. 2005. PMID: 17315416 Review.

  • Clinical pharmacology of tramadol.

    Grond S, Sablotzki A. Grond S, et al. Clin Pharmacokinet. 2004;43(13):879-923. doi: 10.2165/00003088-200443130-00004. Clin Pharmacokinet. 2004. PMID: 15509185 Review.

  • Mechanistic and functional differentiation of tapentadol and tramadol.

    Raffa RB, Buschmann H, Christoph T, Eichenbaum G, Englberger W, Flores CM, Hertrampf T, Kögel B, Schiene K, Straßburger W, Terlinden R, Tzschentke TM. Raffa RB, et al. Expert Opin Pharmacother. 2012 Jul;13(10):1437-49. doi: 10.1517/14656566.2012.696097. Epub 2012 Jun 15. Expert Opin Pharmacother. 2012. PMID: 22698264 Review.

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources